September 30, 2016 7:25 PM ET


Company Overview of PhaseBio Pharmaceuticals, Inc.

Key Executives for PhaseBio Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Jonathan P. Mow MBA8 RelationshipsChief Executive Officer and Director51
Ashutosh Chilkoti Ph.D.8 RelationshipsCo-Founder and Director--
Clay Bernardin Thorp 56 RelationshipsExecutive Chairman47
John P. Sharp CPANo RelationshipsChief Financial Officer51
John S. Lee M.D., Ph.D.No RelationshipsChief Medical Officer--

PhaseBio Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Clay Bernardin Thorp 56 RelationshipsPhaseBio Pharmaceuticals, Inc.47
Jonathan P. Mow MBA 8 RelationshipsPhaseBio Pharmaceuticals, Inc.51
Ashutosh Chilkoti Ph.D. 8 RelationshipsPhaseBio Pharmaceuticals, Inc.--
Guy Fish M.D. 8 RelationshipsFletcher Spaght Ventures, LP--
Asish K. Xavier Ph.D. 28 RelationshipsJohnson & Johnson Innovation - JJDC, Inc.--
View All Board Members

PhaseBio Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
There is no committee data available.
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Total Short Term Compensation
Total Value of Options
Compensation as of Fiscal Year
PhaseBio Pharmaceuticals, Inc. CEO Compensation
Industry Average


Medibio Limited Announces Resignation of James Campbell as Non-Executive Director
September 30, 2016 3:22 AM ET
Threshold Pharmaceuticals Inc. to Implement Workforce Reduction; Announces Resignation of Stewart Kroll as Chief Operating Officer
September 29, 2016 9:20 PM ET
Kite Pharma, Inc. Appoints Christine Cassiano as Senior Vice President of Corporate Communications and Investor Relations
September 29, 2016 8:05 PM ET
Diffusion Pharmaceuticals Inc. Announces Establishment of New Scientific Advisory Board
September 29, 2016 2:05 PM ET
Flexion Therapeutics, Inc. Announces Appointment of John Magee as Vice President of Sales
September 29, 2016 12:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact PhaseBio Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at